Estee Lauder Cos에 대한 매도 수량은 투자자에게 Estee Lauder Cos의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Estee Lauder Cos (NYSE:EL) 주식, 공매도 수량 보고

ESTEE LAUDER COMPANIES-CL A

Estee Lauder Cos

Estée Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Estee,Lauder,Store,Sign,Close-up.,Estee,Lauder,Is,A,Luxury

News

Hedge Funds

Management

Movers

Trading Ideas

에스티로더 컴퍼니즈(NYSE:EL) 주가는 지난 3개월 동안 꾸준히 상승했다. 창립자 에스티 로더의 장남이자 오랜 임원이었던 레너드 로더의 사망 소식에 따라 월요일(16일)에는 10% 이상 급등하기도 했다. 

누구보다 먼저 예측한 마이클 버리, 이후 극적인 전환 맞이한 에스티로더

Kuala,Lumpur,,Malaysia,-,November,08,,2023:,Makeup,Products,On

Technicals

에스티로더 컴퍼니즈(NYSE:EL)의 주가는 화요일 0.32% 소폭 상승 마감했다. 이는 주가가 월요일에 10% 이상 상승한 후의 일이다. 주가는 $74.75에서 저항선에 부딪치면서 상승세가 멈췄다. 우리는 에스티로더를 오늘의 주식으로 선정했다. 어제의 랠리가 그 지점에서 끝난 것은 우연이 아니며, 주가는 갭을 메우기 직전일 수 있다.

오늘의 주식: 에스티로더 주가는 저항선 뚫고 갭 메울까?

Bear,Walks,On,Chinese,Yuan,Renminbi,Bill,Banknotes,Background.,China

Options

Global

Markets

Tech

BABA

BIDU

NVDA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

마이클 버리는 2008년 미국 주택 시장에 대한 높은 수익을 올린 베팅으로 유명하며, 최근 중국 기술주에 대해 약세로 전환했다. 버리의 전환은 이전에 중국 기술 기업들에 대해 강세를 보였고, 최근 2024년 말까지 알리바바 그룹 홀딩(NYSE:BABA)와 JD닷컴(NASDAQ:JD)과 같은 기업들에 상당한 롱 포지션을 보유하고 있었기 때문에 주목할 만하다.

&#39;빅 쇼트&#39; 투자자 마이클 버리, 중국에 대해 약세 전환: 그가 지금 공개한 매도 목록은?

Estee Lauder Companies, Inc. (The) Common Stock

The Estee Lauder Companies Inc

ELYSIA

Envela Corp

Elastos - United States Dollar

PMGC Holdings Inc

ELATE HLDGS LTD PCL by ELATE HLDGS LTD PUBLIC COMPANY LIMITED

Elate Holdings Ltd

EL AL ISRAEL AIRLS LTD by EL AL Israel Airlines Ltd.

El AL Israel Airlines Ltd

ELAMEX S.A. DE C.V. by Elamex S.A. de C.V.

Elamex SA de CV

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health Inc

ELBIT MEDICAL TECHS by Elbit Medical Technologies Ltd

Elbit Medical Technologies Ltd

Electra Battery Materials Corporation - Common Stock

Electra Battery Materials Corp

Entergy Louisiana, Inc. Collateral Trust Mortgage Bonds, 4.875 % Series due September 1, 2066

ELECO HOLDINGS PLC by ELECO HOLDINGS PLC

ELECTRA STONE LTD ORD by Electra Stone Ltd

Electra Stone Ltd

Elecom Co Ltd

ELCOM INTL INC by Elcom International, Inc.

Elcom International Inc

EDP-Energias De Portugal SA

ELECTRIC CAR CO INC by Electric Car Company, Inc.

Electric Car Co Inc

Strategy Shares Eventide High Dividend ETF

WisdomTree Emerging Markets Local Debt Fund

ELECTRUM DISCOVERY CORP by ELECTRUM DISCOVERY CORP.

Electrum Discovery Corp

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals Inc

El.En. SpA

ELECTRIC ROYALTIES LTD by Electric Royalties Ltd.

Electric Royalties Ltd

ELEMENT FLEET MGMT CORP by Element Fleet Mgmt Corp.

Element Fleet Management Corp

Elektros Inc

ELEMENTAL ALTUS ROYALTIES by ELEMENTAL ALTUS ROYALTIES CORP.

Elemental Altus Royalties Corp

Elevation Oncology Inc

Endesa SA

e.l.f. Beauty Inc

aelf

E-L Financial Corp Ltd

ALPS Electrification Infrastructure ETF

ELEMENT GLOBAL INC by Element Global, Inc.

Element Global Inc

ELECTRIC & GAS TECH INC by Electric & Gas Technology, Inc.

ELIA SYSTEM OPERATOR SA by Elia System Operator SA/NV

Elia Group SA/NV

Direxion Daily LLY Bull 2X Shares

Elio Motors Inc

ELECTRIQ POWER HLDGS A by Electriq Power Holdings Inc.

Electriq Power Holdings Inc

Electriq Power Holdings Inc Warrants (25/01/2028)

Direxion Daily LLY Bear 1X Shares

Elixxer Ltd

Elkem ASA

GOLD ROAD RES LTD ORD by Gold Road Resources Ltd.

Gold Road Resources Ltd

Elah Holdings Inc

Ellaktor SA

Ellomay Capital Ltd Ordinary Shares (Israel)

Ellomay Capital Ltd

ELRINGKLINGER AG UNSP/ADR by Elringklinger Ag

ElringKlinger AG

Elixinol Wellness Ltd Ordinary Shares

ELIXINOL WELLNESS LTD by Elixinol Wellness Ltd.

Elixinol Wellness Ltd

Series Portfolios Trust Elm Market Navigator ETF

Elmer Bancorp Inc

Electromed Inc

Elme Communities

Element79 Gold Corp

ELEMENT79 GOLD CORP by Element79 Gold Corp.

Elemon

ELECTRIC LAST MILE SOLN A by Electric Last Mile Solutions Inc.

Electric Last Mile Solutions Inc

Element 25 Ltd

Elementis PLC

Elisa Oyj

Electric Last Mile Solutions Inc Warrants (24/06/2026)

ELANIX BIOTECHNOLOGIES AG by ELANIX BIOTECHNOLOGIES AG

Elecnor SA

Element Nutritional Sciences Inc Ordinary Shares

Elinx Corp

EMERGENCE GLOBAL ENTRPSE by EMERGENCE GLOBAL ENTERPRISES INC.

Tidal Trust III Battleshares TSLA vs F ETF

Dogelon Mars

Elior Group SA

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals Inc

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)

Cia Paranaense De Energia Copel

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing four (4) Common Shares)

Elopak ASA

EL PUERTO LIVERPOOL SHS 1 by El Puerto de Liverpool S.A. de C.V.

El Puerto de Liverpool SAB de CV

Elong Power Holding Limited - Class A Ordinary Shares

Elong Power Holding Ltd

iShares ESG Advanced Investment Grade Corporate Bond ETF

ELRAY RESOURCES INC by Elray Resources, Inc.

Elray Resources Inc

Yinfu Gold Corp

EASTERN PLATINUM LTD NEW by Eastern Platinum Ltd.

Eastern Platinum Ltd

ELRON VENTURES LTD by Elron Ventures Ltd.

Elron Ventures Ltd

ELORO RESOURCES LTD by Eloro Resources Ltd.

Eloro Resources Ltd

AKTIEBOLAGET ELECTROLUX B by AB Electrolux

Electrolux AB

Equity Lifestyle Properties, Inc. Common Stock

Equity Lifestyle Properties Inc

Electro-Sensors Inc

Elis SA

ELECTRONIC SYS TECHNOLOGY by Electronic Systems Technology, Inc.

Electronic Systems Technology Inc

Eltek Ltd

Elementos Ltd

ELITE PHARMS INC by Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Inc

ELMOS SEMICONDUCTOR AG by Elmos Semiconductor AG

Elmos Semiconductor SE

Elicio Therapeutics Inc

Elutia Inc

Estée Lauder Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) stock has climbed steadily over the past three months and jumped more than 10% on Monday following the death of<a href="https://www.benzinga.com/news/entertainment/25/06/45943408/leonard-lauder-visionary-behind-estee-lauders-global-expansion-and-creator-of-clinique-aramis-dies-at-92"> Leonard Lauder,</a><a href="https://www.benzinga.com/news/entertainment/25/06/45943408/leonard-lauder-visionary-behind-estee-lauders-global-expansion-and-creator-of-clinique-aramis-dies-at-92"> a longtime executive and son of founder Estée Lauder.&nbsp;</a>
Estée Lauder is Michael Burry's only current long position. Here's what to know: 
The Details: According to its most recent SEC filing, Burry&#8217;s hedge fund Scion Asset Management <a href="https://www.benzinga.com/news/large-cap/25/05/45499101/big-short-legend-michael-burry-bets-big-on-lipstick-index-is-he-bracing-for-a-recession">doubled its stake</a> in Estée Lauder in the first quarter of 2025.&nbsp;
Read Next:<a href="https://www.benzinga.com/markets/tech/25/06/45971345/sunrun-first-solar-plunge-solar-stocks-hit-hard-by-trump-tax-bill-latest?utm_source=articleShare"> Sunrun, First Solar Plunge—Solar Stocks Hit Hard By Trump Tax Bill: Latest</a>&nbsp;
During the first quarter, the investment firm purchased an additional 100,000 shares in the world's second-largest cosmetics company, bringing its total holdings to 200,000 shares.&nbsp;
Estée Lauder: Leonard Lauder, the influential executive who guided Estée Lauder from a single-brand operation to a global leader in the beauty industry, passed away last Saturday at the age of 92.
Shares of Estée Lauder stock jumped 10% in Monday's session following the death of Lauder. 
While it is unlikely that Burry foresaw a stock jump correlated to the death of a company executive, he did double his stake in the company and held it as his firm's only long position.&nbsp;
Burry&#8217;s move could reflect a strategic bet on a recession and the so-called "Lipstick Index," which suggests consumers turn to more affordable luxuries like cosmetics<a href="https://www.benzinga.com/markets/25/05/45484735/michael-burry-makes-major-portfolio-shift-holding-only-one-asset-he-deems-recession-proof"> during economic downturns.</a>
&#8220;In the 2008 recession, cosmetics sales increased, showing that even in tough times, individuals crave tiny comfort purchases that give psychological boosts without a hefty financial outlay,&#8221; Kevin Shahnazari, founder of FinlyWealth, told LevelFields.
EL Price Action: Estée Lauder shares ended Tuesday's session&nbsp;up 0.27% at $74.79, according to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>.&nbsp;
Read Next:<a href="https://www.benzinga.com/news/retail-sales/25/06/45953480/alibaba-pdd-stocks-climb-chinas-retail-sector-gains-despite-us-tariffs?utm_source=articleShare">&nbsp;</a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/retail-sales/25/06/45953480/alibaba-pdd-stocks-climb-chinas-retail-sector-gains-despite-us-tariffs?utm_source=articleShare">Alibaba, PDD Stocks Climb As China&#8217;s Retail Sector Gains Despite US Tariffs</a></li>
</ul>
Photo: Shutterstock

Michael Burry Saw It Before Anyone Else — Then Estée Lauder's Story Took A Dramatic Turn

The stock of The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) is consolidating Tuesday. This comes after the shares gained more <a href="https://www.benzinga.com/news/25/06/45951987/sage-therapeutics-roku-echostar-and-other-big-stocks-moving-higher-on-monday">than 10% on Monday</a>. The move higher ended when they slammed into resistance around $74.75.
Estee Lauder is our Stock of the Day. It isn't a coincidence yesterday's rally ended where it did, and the shares may be about to fill a gap.
Some analysts believe the market follows a &#8220;random walk.&#8221; They believe that it is impossible to time the market.
These analysts are wrong.
If the market followed a random path, no price level would be more important than any other. But a chart will show that some levels are clearly more important than others. These are called support and resistance levels.
Estee Lauder ran into resistance around $74.75. It wasn't random and it wasn't a coincidence.
There was resistance at this price because it was resistance in late February.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="565" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17153729/EL-1024x565.png" alt="" class="wp-image-952955" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17153729/EL-1024x565.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17153729/EL-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17153729/EL-768x424.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17153729/EL.png 1471w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45978856/federal-reserve-rate-cuts-trump-tariffs-what-to-watch-wednesday">No Rate Cuts Yet, Fed Wants To See Where Tariffs Land: Here&#8217;s What To Watch Wednesday</a>
Many of the traders and investors who bought shares then decided they made a mistake when the price dropped. Some also decided to sell their shares if they could eventually do so at breakeven.
So, when the shares reached $74.75, these remorseful buyers flooded the market as sellers. Their selling put a top on the price.
If the buyers can overpower the sellers who created the resistance, there is a good chance the stock makes a rapid move higher.
One of the main reasons for market resistance is buyer's remorse. This is why there was some around $74.75.
As you can see on the chart, in January Estee Lauder gapped down from around $80.80 to around $74.75. When a stock gaps from one price to another, there is no trading at the levels between the two prices.
If there was no trading, there would be no remorseful buyers trying to sell on the way up. This means there may not be significant sell interest if the stock gets back to these levels heading in the opposite direction.
Buyers will be forced to outbid each other and pay successively higher prices to draw sellers back into the market. This price action could force Estee Lauder higher.
Read Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/markets/market-summary/25/06/45981450/wall-street-drops-as-trump-weighs-iran-action-defense-stocks-jump-whats-driving-markets-tuesday">Wall Street Drops As Trump Weighs Iran Action, Defense Stocks Jump: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Photo: Sorbis On Shutterstock.com

Stock Of The Day: Will Estee Lauder Fill The Gap?

U.S. stocks were higher, with the Dow Jones index gaining around 500 points on Monday.
Shares of Sage Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) rose sharply during Monday's session after Supernus Pharmaceuticals <a href="https://www.benzinga.com/quote/SAGE">agreed to acquire the company</a>.
Supernus Pharmaceuticals on Monday agreed to acquire Sage Therapeutics for $12.00 per share in cash, or an aggregate of up to approximately $795 million.
The deal consideration includes $8.50 per share in cash (or an aggregate of approximately $561 million) plus one non-tradable contingent value right (CVR) collectively worth up to $3.50 per share in cash (or an aggregate of approximately $234 million).
Sage Therapeutics shares climbed 35.6% to $9.09 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) shares jumped 48.2% to $24.96 after President Trump reportedly urged Ergen and Carr to cut a deal on the company&#8217;s spectrum.</li>
<li>AIRO Group Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRO#NASDAQ">AIRO</a>) jumped 42% to $31.11 after jumping 140% on Friday. AIRO Group priced its $60 million initial public offering of 6 million common shares at $10 per share.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) gained 22.1% to $163.13.</li>
<li>Arqit Quantum Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) rose 21% to $28.77.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) gained 17.4% to $35.83. NANO Nuclear Energy announced that Matthew Barry has joined the Company as its Director of Investor Relations.</li>
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) rose 17.4% to $21.63.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) rose 17.1% to $5.08 after Korea Zinc announced an equity investment of $85.2 million in the company.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) climbed 17% to $14.05.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) surged 15.6% to $19.17.</li>
<li>NextNav Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NN#NASDAQ">NN</a>) gained 15.6% to $14.88.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) rose 10.3% to $82.06 after the company announced a new integration with Amazon Ads.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) gained 10.2% to $61.17.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) rose 10% to $42.21.</li>
<li>Uranium Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UEC#NYSE">UEC</a>) gained 9.8% to $6.87.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) rose 9.5% to $5.74.</li>
<li>Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) gained 9.1% to $39.28. Darling Ingredients announced offering of €750 Million of senior notes by Darling Global Finance B.V. and proposed entry into a new amended and restated credit agreement.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) rose 9% to $33.42.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) surged 8.5% to $126.01.</li>
<li>The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) gained 7.9% to $72.67.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) climbed 6% to $71.15. Marvell Technology announced a quarterly dividend of 6 cents per share of common stock.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45946608/top-3-materials-stocks-that-could-blast-off-this-month-3">Top 3 Materials Stocks That Could Blast Off This Month</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

AIRO

ARQQ

ASTS

CRCL

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MRVL

QUBT

ROKU

SAGE

SATS

TSSI

URGN

Sage Therapeutics, Roku, EchoStar And Other Big Stocks Moving Higher On Monday

Leonard Lauder, the longtime executive who transformed Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) from a single-brand business into a global beauty powerhouse, died Saturday at the age of 92.&nbsp;
What Happened: Lauder, son of company founders Estée and Joseph Lauder, joined the family business in 1958.
Over the next six decades, he played a pivotal role in expanding the company's footprint beyond U.S. department stores, launching iconic brands such as Aramis, Clinique and Lab Series.
He served in various leadership roles, eventually becoming chairman and later chairman emeritus of The Estée Lauder Companies Inc.
A private memorial service will be held for close friends and family, the company said.
See Also: <a href="https://www.benzinga.com/25/05/45179419/estee-lauders-beauty-gains-cant-offset-global-headwinds-says-analyst">Estée Lauder&#8217;s Beauty Gains Can&#8217;t Offset Global Headwinds, Says Analyst</a>
Why It's Important: Last month, Estée Lauder reported <a href="https://www.benzinga.com/25/05/45179419/estee-lauders-beauty-gains-cant-offset-global-headwinds-says-analyst">mixed third-quarter results</a>. While adjusted EPS of 65 cents beat expectations of 32 cents and sales of $3.55 billion topped estimates, revenue fell 10% year-over-year.
Organic net sales dropped 9%, with declines across all product categories — including an 11% drop in Skin Care, 7% in Makeup, 1% in Fragrance, and 10% in Hair Care — driven by weaker performance in travel retail and lower product launches.
Price Action: Estée Lauder shares edged up 0.13% to $67.40 in after-hours trading, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Benzinga's Edge Stock Rankings indicate a steady upward trend for EL in the short and medium term, though the stock shows a downward trajectory over the long term. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Further performance insights are available here</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45889800/dow-jones-breaks-43000-palantir-hits-new-record-highs-whats-driving-markets-wednesday" target="_blank" rel="noreferrer noopener">Dow Jones Breaks 43,000, Palantir Hits New Record Highs: What&#8217;s Driving Markets Wednesday?</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

General

Leonard Lauder, Visionary Behind Estée Lauder's Global Expansion And Creator Of Clinique, Aramis, Dies At 92

Estee Lauder Cos's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) short percent of float has risen 15.06% since its last report. The company recently reported that it has 10.29 million shares sold short, which is 4.43% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.77 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Estee Lauder Cos Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749218430_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Estee Lauder Cos has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Estee Lauder Cos's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Estee Lauder Cos's peer group average for short interest as a percentage of float is 5.85%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Estee Lauder Cos's Recent Short Interest

Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Estee Lauder Cos, revealing an average target of $66.64, a high estimate of $90.00, and a low estimate of $55.00. Highlighting a 10.9% decrease, the current average has fallen from the previous average price target of $74.79. 
<img src="https://www.benzinga.com/files/images/story/2025/1748541709_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Estee Lauder Cos. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$63.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$62.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$66.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$62.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Christopher Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$67.00</td>
<td>$77.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Estee Lauder Cos. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Estee Lauder Cos compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Estee Lauder Cos's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Estee Lauder Cos analyst ratings.</a>
<h2>Unveiling the Story Behind Estee Lauder Cos</h2>
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
<h3>Estee Lauder Cos: Delving into Financials</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Decline in Revenue: Over the 3M period, Estee Lauder Cos faced challenges, resulting in a decline of approximately -9.9% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Estee Lauder Cos's net margin is impressive, surpassing industry averages. With a net margin of 4.48%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Estee Lauder Cos's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.74% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.8%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.16, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About Estee Lauder Cos Stock

Barclays analyst Lauren Lieberman maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Equal-Weight and raises the price target from $56 to $63.

Price Target

Barclays Maintains Equal-Weight on Estee Lauder Cos, Raises Price Target to $63

Activist investor&nbsp;Dan&nbsp;Loeb‘s&nbsp;Third Point LLC&nbsp;acquired a significant stake in consumer health company&nbsp;Kenvue Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>)&nbsp;<a target="_blank" href="https://www.benzinga.com/topic/dan-loeb" rel="noreferrer noopener">in the first quarter of 2025</a>.
Kenvue was formerly a part of&nbsp;Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) before becoming an independent&nbsp;<a href="https://www.benzinga.com/news/large-cap/24/08/40659011/johnson-johnson-spin-off-kenvue-wins-lawsuit-over-pain-killer-tylenol-rapid-release-gelcaps" target="_blank" rel="noreferrer noopener">company in August 2023</a>.
The company&#8217;s major products include several J&amp;J brands, including Tylenol, <a href="https://www.benzinga.com/news/large-cap/23/05/32205951/kenvues-ipo-extravaganza-a-historic-41-billion-spinoff-from-johnson-johnson">Listerine, Neutrogena, and Nicorette</a>.&nbsp;
According to recent 13F filings, reflecting his holding as of March 31, 2025, Loeb bought an 8.9 million stake in the company, thereby placing it <a target="_blank" href="https://www.benzinga.com/news/large-cap/25/05/45472025/loebs-third-point-exits-meta-tesla-rotates-into-staples-telecom-industrials" rel="noreferrer noopener">among his top five holdings</a>.
Let's have a look at the company&#8217;s major events.
<ul class="wp-block-list">
<li>On May 8, the company reported first-quarter 2025 sales of $3.74 billion, beating <a href="https://www.benzinga.com/general/health-care/25/05/45297027/neutrogena-maker-kenvue-beats-profit-forecast-ups-sales-outlook" target="_blank" rel="noreferrer noopener">the&nbsp;consensus of $3.68 billion</a>.</li>
<li>Kenvue updated its fiscal 2025 outlook to reflect current foreign exchange rates and the estimated impact of <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">higher costs due to tariffs</a>.&nbsp;</li>
<li>The company now expects a net sales increase of +1% to +3% (-1% to +1% prior) year-over-year, with organic sales growth of +2% to +4 (unchanged) and a ~1% headwind from foreign currency translation <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">(earlier expected around 3%)</a>.</li>
<li>Also, Kenvue appointed Amit Banati as the company's CFO, effective May 12. Banati will <a href="https://www.benzinga.com/pressreleases/25/05/b45280347/kenvue-announces-chief-financial-officer-transition" target="_blank" rel="noreferrer noopener">succeed Paul Ruh</a>.</li>
<li>On April 16, Kenvue announced a five-year collaboration with Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) to establish a strong foundation for transforming digital operations through advanced&nbsp;<a href="https://www.benzinga.com/pressreleases/25/04/b44834009/kenvue-announces-5-year-collaboration-with-microsoft-to-transform-digital-operations" target="_blank" rel="noreferrer noopener">Artificial Intelligence (AI) technologies</a>.</li>
<li>Kenvue shares rose nearly 11.5% year to date, compared to the&nbsp;Renaissance IPO ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPO#NYSE">IPO</a>), which fell about 1.36%&nbsp;over the same time frame.</li>
<li>The company&#8217;s shares also fared well compared to its closest peer, Estee Lauder Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>), which declined 15.06% year to date.</li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45528489/loebs-third-point-boosts-apollo-stake-275-soho-house-121-in-q1-bet" target="_blank" rel="noreferrer noopener">Loeb&#8217;s Third Point Boosts Apollo Stake 275%, Soho House 121% In Q1 Bet</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Large Cap

KVUE

MSFT

Why Dan Loeb Just Made Kenvue One Of His Top Holdings

JPMorgan analyst Christopher Horvers reiterated the Overweight rating on Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>), <a href="https://www.benzinga.com/quote/ULTA/analyst-ratings" target="_blank" rel="noreferrer noopener">raising the price forecast from $475 to $477.</a>
Ulta will report first-quarter earnings on reports Thursday, May 29, after the market close.
Horvers notes that during Ulta&#8217;s fourth-quarter earnings update, the company mentioned comparable sales trends were nearly flat. They&#8217;re starting to improve thanks to the momentum of its semi-annual event and a more stable consumer and beauty market.
Also Read: <a href="https://www.benzinga.com/news/large-cap/25/05/45499101/big-short-legend-michael-burry-bets-big-on-lipstick-index-is-he-bracing-for-a-recession" target="_blank" rel="noreferrer noopener">&#8216;Big Short&#8217; Legend Michael Burry Bets Big On Lipstick Index: Is He Bracing For A Recession?</a>
Broadly, the analyst sees beauty category growth normalizing to its historical 3%-4% range, positioning Ulta to gain share thanks to its unique mix of mass and prestige offerings and strong industry position. This, Horvers writes, should lead to better margin conversion, earnings growth, and potential multiple expansion.
The analyst also points out that, during the firm&#8217;s April 3 RRU conference, Ulta Beauty CEO Kecia Steelman maintained a positive outlook. She highlighted consistent consumer behavior since the Q4 report and strong performance during promotional periods, even as overall engagement remained soft in quieter times.
Horvers observes that since Ulta's last report, quarter-to-date trends have shown modest improvement—about 50 basis points—according to Nielsen and Circana data, with momentum building sequentially from January through March.
Additional insights from Coty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) and Estee Lauder Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) suggest that April performed better than March. Based on this, the analyst has raised its forecast to 0.7%.
Although Ulta did not offer formal second-quarter guidance, Horvers notes that management expects comparable sales to remain roughly in line, with the second and third quarters benefiting from easier year-over-year comparisons.
While consumer behavior appears stable or slightly better than a year ago, fading market share pressures and stronger execution should support improvement.
Price Action: Ulta Beauty shares are trading lower by 1.38% to $405.04 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45553623/retail-etfs-rattle-as-tariffs-yields-consumer-caution-pressure-big-box-stocks" target="_blank" rel="noreferrer noopener">Retail ETFs Rattle As Tariffs, Yields, Consumer Caution Pressure Big-Box Stocks</a></li>
</ul>
Image: Shutterstock

Comments

Estee Lauder Cos

매도 수량

Estee Lauder Cos (NYSE:EL) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌